The oncoprotein DEK affects the outcome of PARP1/2 inhibition during mild replication stress-Reference-Cited by-同舟云学术

The oncoprotein DEK affects the outcome of PARP1/2 inhibition during mild replication stress

Published:2019-08-13 Issue:8 Volume:14 Page:e0213130
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Ganz Magdalena,Vogel Christopher,Czada Christina,Jörke Vera,Gwosch Eva Christina,Kleiner Rebecca,Pierzynska-Mach Agnieszka,Zanacchi Francesca Cella,Diaspro Alberto,Kappes Ferdinand^ORCID,Bürkle Alexander,Ferrando-May Elisa^ORCID

Funder

Deutsche Forschungsgemeinschaft

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference73 articles.

1. PARPs in genome stability and signal transduction: implications for cancer therapy;L Palazzo;Biochem Soc Trans,2018

2. Biology of Poly(ADP-Ribose) Polymerases: The Factotums of Cell Maintenance;P. Bai;Molecular cell,2015

3. Splitting of the ribose-ribose linkage of poly(adenosine diphosphate-robose) by a calf thymus extract;M Miwa;J Biol Chem,1971

4. Using PARP Inhibitors in the Treatment of Patients With Ovarian Cancer.;KC Kurnit;Curr Treat Options Oncol,2018

5. Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase;HE Bryant;Nature,2005

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DEK oncoprotein participates in heterochromatin replication via SUMO-dependent nuclear bodies;Journal of Cell Science;2023-12-01

2. Super-resolution microscopy reveals the nanoscale cluster architecture of the DEK protein cancer biomarker;iScience;2023-11

3. Imaging-based study demonstrates how the DEK nanoscale distribution differentially correlates with epigenetic marks in a breast cancer model;Scientific Reports;2023-08-07

4. DEK oncoprotein participates in heterochromatin replication via SUMO-dependent nuclear bodies;2023-03-10

5. Super-resolution microscopy reveals the nanoscale organization of the DEK protein cancer biomarker;2023-03-01